{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:30Z","timestamp":1786437030528,"version":"build-2736575974"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL174510"],"award-info":[{"award-number":["R01HL174510"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL160992"],"award-info":[{"award-number":["R01HL160992"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10740-9","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:28:01Z","timestamp":1785882481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular mechanisms, therapeutic strategies, and inter-organ fibrosis crosstalk of Gla proteins in cardiovascular disease"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0006-8987","authenticated-orcid":false,"given":"Shuai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siena","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan O.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5044-672X","authenticated-orcid":false,"given":"Xander H. T.","family":"Wehrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"10740_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.molmed.2022.07.002","volume":"28","author":"J Welsh","year":"2022","unstructured":"Welsh, J., Bak, M. J. & Narvaez, C. J. New insights into vitamin K biology with relevance to cancer. Trends Mol. Med. 28, 864\u2013881 (2022).","journal-title":"Trends Mol. Med."},{"key":"10740_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0734-3","volume":"9","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis. Cell Death Dis. 9, 691 (2018).","journal-title":"Cell Death Dis."},{"key":"10740_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/1878-0261.12652","volume":"14","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Intracellular matrix Gla protein promotes tumor progression by activating JAK2\/STAT5 signaling in gastric cancer. Mol. Oncol. 14, 1045\u20131058 (2020).","journal-title":"Mol. Oncol."},{"key":"10740_CR4","doi-asserted-by":"crossref","unstructured":"Wu, X. et al. Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis. Eur. Respir. J. 61, 2201799 (2023).","DOI":"10.1183\/13993003.01799-2022"},{"key":"10740_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jcmgh.2023.08.007","volume":"16","author":"ST Hui","year":"2023","unstructured":"Hui, S. T. et al. Role of matrix Gla protein in transforming growth factor-beta signaling and nonalcoholic steatohepatitis in mice. Cell Mol. Gastroenterol. Hepatol. 16, 943\u2013960 (2023).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10740_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/gh.1288","volume":"19","author":"M Di Cesare","year":"2024","unstructured":"Di Cesare, M. et al. The heart of the world. Glob. Heart 19, 11 (2024).","journal-title":"Glob. Heart"},{"key":"10740_CR7","doi-asserted-by":"crossref","unstructured":"Sygitowicz, G., Maciejak-Jastrzebska, A. & Sitkiewicz, D. A review of the molecular mechanisms underlying cardiac fibrosis and atrial fibrillation. J. Clin. Med. 10, 4430 (2021).","DOI":"10.3390\/jcm10194430"},{"key":"10740_CR8","doi-asserted-by":"crossref","unstructured":"Maruyama, K. & Imanaka-Yoshida, K. The pathogenesis of cardiac fibrosis: a review of recent progress. Int. J. Mol. Sci. 23, 2617 (2022).","DOI":"10.3390\/ijms23052617"},{"key":"10740_CR9","doi-asserted-by":"crossref","unstructured":"Severino, P. et al. Myocardial tissue characterization in heart failure with preserved ejection fraction: from histopathology and cardiac magnetic resonance findings to therapeutic targets. Int. J. Mol. Sci. 22, 7650 (2021).","DOI":"10.3390\/ijms22147650"},{"key":"10740_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41569-024-01088-w","volume":"22","author":"U Schotten","year":"2025","unstructured":"Schotten, U., Goette, A. & Verheule, S. Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches. Nat. Rev. Cardiol. 22, 225\u2013240 (2025).","journal-title":"Nat. Rev. Cardiol."},{"key":"10740_CR11","doi-asserted-by":"crossref","unstructured":"Xiao H., Chen J., Duan L., Li S. Role of emerging vitamin K\u2011dependent proteins: growth arrest\u2011specific protein 6, Gla\u2011rich protein and periostin (Review). Int. J. Mol. Med. 47, 2 (2021).","DOI":"10.3892\/ijmm.2020.4835"},{"key":"10740_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"G Luo","year":"1997","unstructured":"Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78\u201381 (1997).","journal-title":"Nature"},{"key":"10740_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/ATVBAHA.114.304823","volume":"35","author":"CS Viegas","year":"2015","unstructured":"Viegas, C. S. et al. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler. Thromb. Vasc. Biol. 35, 399\u2013408 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10740_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3803\/EnM.2023.1895","volume":"39","author":"JK Nowicki","year":"2024","unstructured":"Nowicki, J. K. & Jakubowska-Pietkiewicz, E. Osteocalcin: beyond bones. Endocrinol. Metab. 39, 399\u2013406 (2024).","journal-title":"Endocrinol. Metab."},{"key":"10740_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fmed.2018.00137","volume":"5","author":"LA Law","year":"2018","unstructured":"Law, L. A., Graham, D. K., Di Paola, J. & Branchford, B. R. GAS6\/TAM pathway signaling in hemostasis and thrombosis. Front. Med. 5, 137 (2018).","journal-title":"Front. Med."},{"key":"10740_CR16","doi-asserted-by":"crossref","unstructured":"Galunska, B., Yotov, Y., Nikolova, M. & Angelov, A. Extrahepatic vitamin K-dependent Gla-proteins-potential cardiometabolic biomarkers. Int. J. Mol. Sci. 25, 3517 (2024).","DOI":"10.3390\/ijms25063517"},{"key":"10740_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2014.07.020","volume":"561","author":"ML Cancela","year":"2014","unstructured":"Cancela, M. L., Laize, V. & Conceicao, N. Matrix Gla protein and osteocalcin: from gene duplication to neofunctionalization. Arch. Biochem. Biophys. 561, 56\u201363 (2014).","journal-title":"Arch. Biochem. Biophys."},{"key":"10740_CR18","doi-asserted-by":"crossref","unstructured":"Halder M. et al Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease. Int. J. Mol. Sci. 20, 896 (2019).","DOI":"10.3390\/ijms20040896"},{"key":"10740_CR19","doi-asserted-by":"publisher","first-page":"9058","DOI":"10.1073\/pnas.94.17.9058","volume":"94","author":"JD Kulman","year":"1997","unstructured":"Kulman, J. D., Harris, J. E., Haldeman, B. A. & Davie, E. W. Primary structure and tissue distribution of two novel proline-rich gamma-carboxyglutamic acid proteins. Proc. Natl. Acad. Sci. USA 94, 9058\u20139062 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10740_CR20","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1073\/pnas.98.4.1370","volume":"98","author":"JD Kulman","year":"2001","unstructured":"Kulman, J. D., Harris, J. E., Xie, L. & Davie, E. W. Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. Proc. Natl. Acad. Sci. USA 98, 1370\u20131375 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10740_CR21","doi-asserted-by":"publisher","first-page":"17991","DOI":"10.1074\/jbc.M708029200","volume":"283","author":"DL Coutu","year":"2008","unstructured":"Coutu, D. L. et al. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J. Biol. Chem. 283, 17991\u201318001 (2008).","journal-title":"J. Biol. Chem."},{"key":"10740_CR22","doi-asserted-by":"publisher","first-page":"e0135374","DOI":"10.1371\/journal.pone.0135374","volume":"10","author":"DS Annis","year":"2015","unstructured":"Annis, D. S. et al. Absence of vitamin K-dependent gamma-carboxylation in human periostin extracted from fibrotic lung or secreted from a cell line engineered to optimize gamma-carboxylation. PLoS ONE 10, e0135374 (2015).","journal-title":"PLoS ONE"},{"key":"10740_CR23","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3324\/haematol.2019.229047","volume":"105","author":"Z Hao","year":"2020","unstructured":"Hao, Z., Jin, D. Y., Stafford, D. W. & Tie, J. K. Vitamin K-dependent carboxylation of coagulation factors: insights from a cell-based functional study. Haematologica 105, 2164\u20132173 (2020).","journal-title":"Haematologica"},{"key":"10740_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.thromres.2015.01.025","volume":"135","author":"M Caspers","year":"2015","unstructured":"Caspers, M. et al. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain. Thromb. Res. 135, 977\u2013983 (2015).","journal-title":"Thromb. Res."},{"key":"10740_CR25","doi-asserted-by":"crossref","unstructured":"Lacombe, J. & Ferron, M. VKORC1L1, an enzyme mediating the effect of vitamin K in liver and extrahepatic tissues. Nutrients 10, 970 (2018).","DOI":"10.3390\/nu10080970"},{"key":"10740_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1538-7836.2008.02934.x","volume":"6","author":"G Marchetti","year":"2008","unstructured":"Marchetti, G. et al. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J. Thromb. Haemost. 6, 797\u2013803 (2008).","journal-title":"J. Thromb. Haemost."},{"key":"10740_CR27","doi-asserted-by":"crossref","unstructured":"De Vilder, E. Y., Debacker, J. & Vanakker, O. M. GGCX-associated phenotypes: an overview in search of genotype-phenotype correlations. Int. J. Mol. Sci. 18, 240 (2017).","DOI":"10.3390\/ijms18020240"},{"key":"10740_CR28","doi-asserted-by":"crossref","unstructured":"Ghosh, S., Oldenburg, J. & Czogalla-Nitsche, K. J. The role of GRP and MGP in the development of non-hemorrhagic VKCFD1 phenotypes. Int. J. Mol. Sci. 23, 798 (2022).","DOI":"10.3390\/ijms23020798"},{"key":"10740_CR29","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.105.580167","volume":"113","author":"Y Wang","year":"2006","unstructured":"Wang, Y. et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113, 1615\u20131621 (2006).","journal-title":"Circulation"},{"key":"10740_CR30","doi-asserted-by":"publisher","first-page":"14731","DOI":"10.4238\/2015.November.18.38","volume":"14","author":"Y Li","year":"2015","unstructured":"Li, Y., Zhu, J. & Ding, J. Q. VKORC1 rs2359612 and rs9923231 polymorphisms correlate with high risks of cardiovascular and cerebrovascular diseases. Genet Mol. Res. 14, 14731\u201314744 (2015).","journal-title":"Genet Mol. Res."},{"key":"10740_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/382448a0","volume":"382","author":"P Ducy","year":"1996","unstructured":"Ducy, P. et al. Increased bone formation in osteocalcin-deficient mice. Nature 382, 448\u2013452 (1996).","journal-title":"Nature"},{"key":"10740_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-nutr-061121-091348","volume":"43","author":"G Karsenty","year":"2023","unstructured":"Karsenty, G. Osteocalcin: a multifaceted bone-derived hormone. Annu. Rev. Nutr. 43, 55\u201371 (2023).","journal-title":"Annu. Rev. Nutr."},{"key":"10740_CR33","doi-asserted-by":"crossref","unstructured":"Villafan-Bernal. J. R. et al. Carboxylated osteocalcin as an independent predictor of mean arterial pressure and the atherogenic index in adults. Int. J. Mol. Sci. 26, 1733 (2025).","DOI":"10.3390\/ijms26041733"},{"key":"10740_CR34","first-page":"1169","volume":"9","author":"LJ Lambert","year":"2016","unstructured":"Lambert, L. J. et al. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR\/Cas9 technology. Dis. Model Mech. 9, 1169\u20131179 (2016).","journal-title":"Dis. Model Mech."},{"key":"10740_CR35","doi-asserted-by":"publisher","first-page":"e1008361","DOI":"10.1371\/journal.pgen.1008361","volume":"16","author":"CR Diegel","year":"2020","unstructured":"Diegel, C. R. et al. An osteocalcin-deficient mouse strain without endocrine abnormalities. PLoS Genet. 16, e1008361 (2020).","journal-title":"PLoS Genet."},{"key":"10740_CR36","doi-asserted-by":"crossref","unstructured":"Pi, M., Nishimoto, S. K. & Darryl Quarles, L. Explaining divergent observations regarding osteocalcin\/GPRC6A endocrine signaling. Endocrinology 162, bqab011 (2021).","DOI":"10.1210\/endocr\/bqab011"},{"key":"10740_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156332","volume":"170","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. The bone-heart axis: a crucial dialogue in cardiovascular disease. Metabolism 170, 156332 (2025).","journal-title":"Metabolism"},{"key":"10740_CR38","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s00198-017-3994-3","volume":"28","author":"I Levinger","year":"2017","unstructured":"Levinger, I. et al. Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin. Osteoporos. Int. 28, 2265\u20132273 (2017).","journal-title":"Osteoporos. Int."},{"key":"10740_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmmed.2022.970744","volume":"2","author":"Y Kida","year":"2022","unstructured":"Kida, Y. & Yamaguchi, I. The vascular protective effect of matrix Gla protein during kidney injury. Front. Mol. Med. 2, 970744 (2022).","journal-title":"Front. Mol. Med."},{"key":"10740_CR40","doi-asserted-by":"crossref","unstructured":"Kumric, M. et al. Role of matrix Gla protein in the complex network of coronary artery disease: a comprehensive review. Life 11, 737 (2021).","DOI":"10.3390\/life11080737"},{"key":"10740_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.642136","volume":"9","author":"ML Cancela","year":"2021","unstructured":"Cancela, M. L., Laize, V., Conceicao, N., Kempf, H. & Murshed, M. Keutel syndrome, a review of 50 years of literature. Front. Cell Dev. Biol. 9, 642136 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"10740_CR42","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1074\/jbc.M109683200","volume":"277","author":"AF Zebboudj","year":"2002","unstructured":"Zebboudj, A. F., Imura, M. & Bostrom, K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 277, 4388\u20134394 (2002).","journal-title":"J. Biol. Chem."},{"key":"10740_CR43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/CIRCRESAHA.107.166124","volume":"102","author":"Y Yao","year":"2008","unstructured":"Yao, Y., Shahbazian, A. & Bostrom, K. I. Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ. Res. 102, 1065\u20131074 (2008).","journal-title":"Circ. Res."},{"key":"10740_CR44","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1172\/JCI57567","volume":"121","author":"Y Yao","year":"2011","unstructured":"Yao, Y., Jumabay, M., Wang, A. & Bostrom, K. I. Matrix Gla protein deficiency causes arteriovenous malformations in mice. J. Clin. Invest. 121, 2993\u20133004 (2011).","journal-title":"J. Clin. Invest."},{"key":"10740_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jbmr.2039","volume":"29","author":"Z Khavandgar","year":"2014","unstructured":"Khavandgar, Z. et al. Elastin haploinsufficiency impedes the progression of arterial calcification in MGP-deficient mice. J. Bone Min. Res. 29, 327\u2013337 (2014).","journal-title":"J. Bone Min. Res."},{"key":"10740_CR46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1160\/TH08-02-0087","volume":"100","author":"LJ Schurgers","year":"2008","unstructured":"Schurgers, L. J., Cranenburg, E. C. & Vermeer, C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb. Haemost. 100, 593\u2013603 (2008).","journal-title":"Thromb. Haemost."},{"key":"10740_CR47","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/labinvest.3700667","volume":"87","author":"D Gheduzzi","year":"2007","unstructured":"Gheduzzi, D. et al. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 87, 998\u20131008 (2007).","journal-title":"Lab. Invest."},{"key":"10740_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3945\/an.111.001826","volume":"3","author":"S Laurance","year":"2012","unstructured":"Laurance, S., Lemarie, C. A. & Blostein, M. D. Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv. Nutr. 3, 196\u2013203 (2012).","journal-title":"Adv. Nutr."},{"key":"10740_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nchembio.1636","volume":"10","author":"MS Kariolis","year":"2014","unstructured":"Kariolis, M. S. et al. An engineered Axl \u2018decoy receptor\u2019 effectively silences the Gas6-Axl signaling axis. Nat. Chem. Biol. 10, 977\u2013983 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"10740_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0014-5793(97)00448-1","volume":"408","author":"K Tanabe","year":"1997","unstructured":"Tanabe, K. et al. Roles of gamma-carboxylation and a sex hormone-binding globulin-like domain in receptor-binding and in biological activities of Gas6. FEBS Lett. 408, 306\u2013310 (1997).","journal-title":"FEBS Lett."},{"key":"10740_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1121130","volume":"13","author":"X Zhai","year":"2023","unstructured":"Zhai, X. et al. Gas6\/AXL pathway: immunological landscape and therapeutic potential. Front. Oncol. 13, 1121130 (2023).","journal-title":"Front. Oncol."},{"key":"10740_CR52","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Cardiomyocyte proliferation is promoted by intracellular Gas6-mediated Yap activity during neonatal heart regeneration. Eur. Heart J. 45, (2024).","DOI":"10.1093\/eurheartj\/ehae666.3659"},{"key":"10740_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jare.2024.04.020","volume":"70","author":"C Lu","year":"2025","unstructured":"Lu, C. et al. Pleiotropic role of GAS6 in cardioprotection against ischemia-reperfusion injury. J. Adv. Res. 70, 481\u2013497 (2025).","journal-title":"J. Adv. Res."},{"key":"10740_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s44161-023-00392-x","volume":"3","author":"Y Shao","year":"2024","unstructured":"Shao, Y. et al. ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury. Nat. Cardiovasc. Res. 3, 28\u201345 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"10740_CR55","unstructured":"Chaudhry, R., Killeen, R. B. & Babiker, H. M. Physiology, Coagulation Pathways. (StatPearls, Treasure Island (FL), 2025)."},{"key":"10740_CR56","unstructured":"Padda, I. S., Zubair, M. & Citla Sridhar, D. Protein C and S (StatPearls, Treasure Island (FL), 2025)."},{"key":"10740_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00346-0","volume":"10","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. The role of phosphatidylserine on the membrane in immunity and blood coagulation. Biomark. Res. 10, 4 (2022).","journal-title":"Biomark. Res."},{"key":"10740_CR58","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/01.ATV.17.8.1539","volume":"17","author":"R Junker","year":"1997","unstructured":"Junker, R., Heinrich, J., Schulte, H., van de Loo, J. & Assmann, G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler. Thromb. Vasc. Biol. 17, 1539\u20131544 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10740_CR59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1161\/CIRCULATIONAHA.108.780759","volume":"118","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi, B. K., Brouwer, J. L., Veeger, N. J. & van der Meer, J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 118, 1659\u20131667 (2008).","journal-title":"Circulation"},{"key":"10740_CR60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jtha.2024.09.016","volume":"23","author":"AK Haj","year":"2025","unstructured":"Haj, A. K. et al. Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank. J. Thromb. Haemost. 23, 171\u2013180 (2025).","journal-title":"J. Thromb. Haemost."},{"key":"10740_CR61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s13238-014-0023-6","volume":"5","author":"T Wu","year":"2014","unstructured":"Wu, T. & Ouyang, G. Matricellular proteins: multifaceted extracellular regulators in tumor dormancy. Protein Cell 5, 249\u2013252 (2014).","journal-title":"Protein Cell"},{"key":"10740_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1276900","volume":"10","author":"T Yoshihara","year":"2023","unstructured":"Yoshihara, T. et al. Mechanisms of tissue degeneration mediated by periostin in spinal degenerative diseases and their implications for pathology and diagnosis: a review. Front. Med. 10, 1276900 (2023).","journal-title":"Front. Med."},{"key":"10740_CR63","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1021\/pr3003722","volume":"12","author":"KW Hallgren","year":"2013","unstructured":"Hallgren, K. W., Zhang, D., Kinter, M., Willard, B. & Berkner, K. L. Methylation of gamma-carboxylated Glu (Gla) allows detection by liquid chromatography-mass spectrometry and the identification of Gla residues in the gamma-glutamyl carboxylase. J. Proteome Res. 12, 2365\u20132374 (2013).","journal-title":"J. Proteome Res."},{"key":"10740_CR64","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nm1619","volume":"13","author":"B Kuhn","year":"2007","unstructured":"Kuhn, B. et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 13, 962\u2013969 (2007).","journal-title":"Nat. Med."},{"key":"10740_CR65","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.20071297","volume":"205","author":"M Shimazaki","year":"2008","unstructured":"Shimazaki, M. et al. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205, 295\u2013303 (2008).","journal-title":"J. Exp. Med."},{"key":"10740_CR66","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/ATVBAHA.115.306397","volume":"36","author":"JA Schwanekamp","year":"2016","unstructured":"Schwanekamp, J. A., Lorts, A., Vagnozzi, R. J., Vanhoutte, D. & Molkentin, J. D. Deletion of periostin protects against atherosclerosis in mice by altering inflammation and extracellular matrix remodeling. Arterioscler. Thromb. Vasc. Biol. 36, 60\u201368 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10740_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2025.101330","volume":"10","author":"T Hayasaka","year":"2025","unstructured":"Hayasaka, T. et al. Periostin is a pivotal target of microRNA-150-5p in cardiac fibroblast activation and chronic myocardial infarction. JACC Basic Transl. Sci. 10, 101330 (2025).","journal-title":"JACC Basic Transl. Sci."},{"key":"10740_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/1479164116653239","volume":"13","author":"SM Gamal","year":"2016","unstructured":"Gamal, S. M., Sadek, N. B., Rashed, L. A., Shawky, H. M. & Gamal El-Din, M. M. Effect of gamma-carboxylase inhibition on serum osteocalcin may be partially protective against developing diabetic cardiomyopathy in type 2 diabetic rats. Diab Vasc. Dis. Res. 13, 405\u2013417 (2016).","journal-title":"Diab Vasc. Dis. Res."},{"key":"10740_CR69","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.amjcard.2010.07.013","volume":"106","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am. J. Cardiol. 106, 1461\u20131465 (2010).","journal-title":"Am. J. Cardiol."},{"key":"10740_CR70","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2014.01.002","volume":"233","author":"A Prats-Puig","year":"2014","unstructured":"Prats-Puig, A. et al. Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome. Atherosclerosis 233, 272\u2013277 (2014).","journal-title":"Atherosclerosis"},{"key":"10740_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.yjmcc.2022.03.003","volume":"167","author":"YL Wang","year":"2022","unstructured":"Wang, Y. L. et al. Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction. J. Mol. Cell Cardiol. 167, 40\u201351 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"10740_CR72","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.jrn.2020.05.013","volume":"31","author":"M Kratz","year":"2021","unstructured":"Kratz, M. et al. Relationship between chronic kidney disease, glucose homeostasis, and plasma osteocalcin carboxylation and fragmentation. J. Ren. Nutr. 31, 248\u2013256 (2021).","journal-title":"J. Ren. Nutr."},{"key":"10740_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64254-9","volume":"16","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Chronic kidney disease is associated with increased risk of sudden cardiac death. Nat. Commun. 16, 9180 (2025).","journal-title":"Nat. Commun."},{"key":"10740_CR74","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.metabol.2013.03.005","volume":"62","author":"CH Jung","year":"2013","unstructured":"Jung, C. H. et al. The preventive effect of uncarboxylated osteocalcin against free fatty acid-induced endothelial apoptosis through the activation of phosphatidylinositol 3-kinase\/Akt signaling pathway. Metabolism 62, 1250\u20131257 (2013).","journal-title":"Metabolism"},{"key":"10740_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","volume":"36","author":"AR Cyr","year":"2020","unstructured":"Cyr, A. R., Huckaby, L. V., Shiva, S. S. & Zuckerbraun, B. S. Nitric oxide and endothelial dysfunction. Crit. Care Clin. 36, 307\u2013321 (2020).","journal-title":"Crit. Care Clin."},{"key":"10740_CR76","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1074248419876632","volume":"25","author":"NB Sadek","year":"2020","unstructured":"Sadek, N. B. et al. The potential role of undercarboxylated osteocalcin upregulation in microvascular insufficiency in a rat model of diabetic cardiomyopathy. J. Cardiovasc. Pharm. Ther. 25, 86\u201397 (2020).","journal-title":"J. Cardiovasc. Pharm. Ther."},{"key":"10740_CR77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3945\/an.111.001644","volume":"3","author":"MK Shea","year":"2012","unstructured":"Shea, M. K. & Holden, R. M. Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv. Nutr. 3, 158\u2013165 (2012).","journal-title":"Adv. Nutr."},{"key":"10740_CR78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molmet.2016.12.006","volume":"6","author":"M Pi","year":"2017","unstructured":"Pi, M., Nishimoto, S. K. & Quarles, L. D. GPRC6A: jack of all metabolism (or master of none). Mol. Metab. 6, 185\u2013193 (2017).","journal-title":"Mol. Metab."},{"key":"10740_CR79","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2174\/0929867325666180716104159","volume":"27","author":"G Bjorklund","year":"2020","unstructured":"Bjorklund, G. et al. The role of matrix gla protein (MGP) in vascular calcification. Curr. Med. Chem. 27, 1647\u20131660 (2020).","journal-title":"Curr. Med. Chem."},{"key":"10740_CR80","doi-asserted-by":"crossref","unstructured":"Bilalic, A. et al. Circulating levels of dephosphorylated-uncarboxylated matrix Gla protein in patients with acute coronary syndrome. Molecules 26, 1108 (2021).","DOI":"10.3390\/molecules26041108"},{"key":"10740_CR81","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036459","volume":"14","author":"AA Berlot","year":"2025","unstructured":"Berlot, A. A. et al. Inactive matrix Gla protein and cardiovascular outcomes: the multi-ethnic study of atherosclerosis. J. Am. Heart Assoc. 14, e036459 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"10740_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117505","volume":"392","author":"AA Berlot","year":"2024","unstructured":"Berlot, A. A. et al. Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the multi-ethnic study of atherosclerosis. Atherosclerosis 392, 117505 (2024).","journal-title":"Atherosclerosis"},{"key":"10740_CR83","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/13813455.2020.1786130","volume":"128","author":"NF Nazifova-Tasinova","year":"2022","unstructured":"Nazifova-Tasinova, N. F. et al. Circulating uncarboxylated matrix Gla protein in patients with atrial fibrillation or heart failure with preserved ejection fraction. Arch. Physiol. Biochem. 128, 1619\u20131629 (2022).","journal-title":"Arch. Physiol. Biochem."},{"key":"10740_CR84","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/CS20100589","volume":"121","author":"T Ueland","year":"2011","unstructured":"Ueland, T. et al. Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure. Clin. Sci. 121, 119\u2013127 (2011).","journal-title":"Clin. Sci."},{"key":"10740_CR85","doi-asserted-by":"publisher","first-page":"e0193967","DOI":"10.1371\/journal.pone.0193967","volume":"13","author":"FF Wei","year":"2018","unstructured":"Wei, F. F. et al. Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction. PLoS ONE 13, e0193967 (2018).","journal-title":"PLoS ONE"},{"key":"10740_CR86","doi-asserted-by":"crossref","unstructured":"Sun, J. et al. Disruption of Abcc6 transporter in zebrafish causes ocular calcification and cardiac fibrosis. Int. J. Mol. Sci. 22, 278 (2020).","DOI":"10.3390\/ijms22010278"},{"key":"10740_CR87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42826-025-00238-6","volume":"41","author":"A Abu-Siniyeh","year":"2025","unstructured":"Abu-Siniyeh, A., Khataibeh, M., Al-Zyoud, W. & Al Holi, M. Zebrafish as a model for human epithelial pathology. Lab. Anim. Res. 41, 6 (2025).","journal-title":"Lab. Anim. Res."},{"key":"10740_CR88","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/advances\/nmab004","volume":"12","author":"MK Shea","year":"2021","unstructured":"Shea, M. K. et al. Perspective: evidence before enthusiasm-A critical review of the potential cardiovascular benefits of vitamin K. Adv. Nutr. 12, 632\u2013646 (2021).","journal-title":"Adv. Nutr."},{"key":"10740_CR89","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3945\/ajcn.2008.27338","volume":"89","author":"MK Shea","year":"2009","unstructured":"Shea, M. K. et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am. J. Clin. Nutr. 89, 1799\u20131807 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"10740_CR90","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3945\/jn.111.139634","volume":"141","author":"MK Shea","year":"2011","unstructured":"Shea, M. K. et al. Circulating uncarboxylated matrix Gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J. Nutr. 141, 1529\u20131534 (2011).","journal-title":"J. Nutr."},{"key":"10740_CR91","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/ajcn\/nqz147","volume":"110","author":"SR Zwakenberg","year":"2019","unstructured":"Zwakenberg, S. R. et al. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 110, 883\u2013890 (2019).","journal-title":"Am. J. Clin. Nutr."},{"key":"10740_CR92","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11255-019-02275-2","volume":"51","author":"T Oikonomaki","year":"2019","unstructured":"Oikonomaki, T. et al. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial. Int Urol. Nephrol. 51, 2037\u20132044 (2019).","journal-title":"Int Urol. Nephrol."},{"key":"10740_CR93","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4103\/1008-682X.172825","volume":"18","author":"R Zhao","year":"2016","unstructured":"Zhao, R., Li, Y. & Dai, W. Serum sex hormone and growth arrest-specific protein 6 levels in male patients with coronary heart disease. Asian J. Androl. 18, 644\u2013649 (2016).","journal-title":"Asian J. Androl."},{"key":"10740_CR94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.clinbiochem.2018.11.018","volume":"64","author":"RM Holden","year":"2019","unstructured":"Holden, R. M. et al. Circulating Gas6 is associated with reduced human carotid atherosclerotic plaque burden in high risk cardiac patients. Clin. Biochem. 64, 6\u201311 (2019).","journal-title":"Clin. Biochem."},{"key":"10740_CR95","first-page":"708","volume":"8","author":"G Caldentey","year":"2019","unstructured":"Caldentey, G. et al. Serum levels of growth arrest-specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care 8, 708\u2013716 (2019).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10740_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03859-w","volume":"21","author":"T Ma","year":"2023","unstructured":"Ma, T. et al. Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial. J. Transl. Med. 21, 21 (2023).","journal-title":"J. Transl. Med."},{"key":"10740_CR97","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/CIRCRESAHA.121.319643","volume":"129","author":"JP Van Beusecum","year":"2021","unstructured":"Van Beusecum, J. P. et al. Growth arrest specific-6 and Axl coordinate inflammation and hypertension. Circ. Res. 129, 975\u2013991 (2021).","journal-title":"Circ. Res."},{"key":"10740_CR98","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.freeradbiomed.2023.11.007","volume":"210","author":"T Ji","year":"2024","unstructured":"Ji, T. et al. GAS6 attenuates sepsis-induced cardiac dysfunction through NLRP3 inflammasome-dependent mechanism. Free Radic. Biol. Med. 210, 195\u2013211 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"10740_CR99","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.7150\/ijbs.104427","volume":"20","author":"H Zhuang","year":"2024","unstructured":"Zhuang, H. et al. High-throughput screening of an FDA-approved compound library reveals a novel GAS6 receptor agonist for therapeutic intervention in septic myocardial and microvascular injury via modulation of danger-associated molecular patterns. Int. J. Biol. Sci. 20, 6222\u20136240 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"10740_CR100","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.115.06254","volume":"67","author":"YF Zhao","year":"2016","unstructured":"Zhao, Y. F. et al. Growth arrest-specific 6 exacerbates pressure overload-induced cardiac hypertrophy. Hypertension 67, 118\u2013129 (2016).","journal-title":"Hypertension"},{"key":"10740_CR101","doi-asserted-by":"crossref","unstructured":"Adepu, S. & Ramakrishna, S. Controlled drug delivery systems: current status and future directions. Molecules 26, 5905 (2021).","DOI":"10.3390\/molecules26195905"},{"key":"10740_CR102","first-page":"6859","volume":"8","author":"H Wu","year":"2015","unstructured":"Wu, H. et al. Possible involvement of TGF-beta\/periostin in fibrosis of right atrial appendages in patients with atrial fibrillation. Int. J. Clin. Exp. Pathol. 8, 6859\u20136869 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10740_CR103","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12265-017-9748-y","volume":"10","author":"HM Norum","year":"2017","unstructured":"Norum, H. M. et al. The notch ligands DLL1 and periostin are associated with symptom severity and diastolic function in dilated cardiomyopathy. J. Cardiovasc. Transl. Res. 10, 401\u2013410 (2017).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10740_CR104","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14051","volume":"53","author":"W Yang","year":"2023","unstructured":"Yang, W., Zhu, Y., Tang, F., Jian, Z. & Xiao, Y. Cardiac proteomic profiling suggests that hypertrophic and dilated cardiomyopathy share a common pathogenetic pathway of the calcium signalling pathway. Eur. J. Clin. Invest. 53, e14051 (2023).","journal-title":"Eur. J. Clin. Invest."},{"key":"10740_CR105","doi-asserted-by":"publisher","first-page":"e0293427","DOI":"10.1371\/journal.pone.0293427","volume":"18","author":"NS Ioakeimidis","year":"2023","unstructured":"Ioakeimidis, N. S. et al. Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy. PLoS ONE 18, e0293427 (2023).","journal-title":"PLoS ONE"},{"key":"10740_CR106","doi-asserted-by":"publisher","first-page":"e0302732","DOI":"10.1371\/journal.pone.0302732","volume":"19","author":"S Andrup","year":"2024","unstructured":"Andrup, S. et al. Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality. PLoS ONE 19, e0302732 (2024).","journal-title":"PLoS ONE"},{"key":"10740_CR107","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pace.13030","volume":"40","author":"LR Jackson","year":"2017","unstructured":"Jackson, L. R. et al. Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? Pacing. Clin. Electrophysiol. 40, 442\u2013450 (2017).","journal-title":"Pacing. Clin. Electrophysiol."},{"key":"10740_CR108","first-page":"408","volume":"43","author":"SY Roh","year":"2020","unstructured":"Roh, S. Y. et al. Molecular signatures of sinus node dysfunction induce structural remodeling in the right atrial tissue. Mol. Cells 43, 408\u2013418 (2020).","journal-title":"Mol. Cells"},{"key":"10740_CR109","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1152\/ajpheart.00335.2010","volume":"299","author":"B Lopez","year":"2010","unstructured":"Lopez, B. et al. Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. Am. J. Physiol. Heart Circ. Physiol. 299, H1\u2013H9 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10740_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4066","volume":"42","author":"S Radhakrishnan","year":"2024","unstructured":"Radhakrishnan, S. et al. Periostin regulates lysyl oxidase through ERK1\/2 MAPK-dependent serum response factor in activated cardiac fibroblasts. Cell Biochem. Funct. 42, e4066 (2024).","journal-title":"Cell Biochem. Funct."},{"key":"10740_CR111","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12872-015-0169-z","volume":"16","author":"H Wu","year":"2016","unstructured":"Wu, H. et al. Resveratrol ameliorates myocardial fibrosis by inhibiting ROS\/ERK\/TGF-beta\/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc. Disord. 16, 5 (2016).","journal-title":"BMC Cardiovasc. Disord."},{"key":"10740_CR112","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s11658-023-00510-4","volume":"28","author":"QB Lu","year":"2023","unstructured":"Lu, Q. B. et al. Disrupted cardiac fibroblast BCAA catabolism contributes to diabetic cardiomyopathy via a periostin\/NAP1L2\/SIRT3 axis. Cell Mol. Biol. Lett. 28, 93 (2023).","journal-title":"Cell Mol. Biol. Lett."},{"key":"10740_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23353-y","volume":"8","author":"BA Willems","year":"2018","unstructured":"Willems, B. A. et al. Ucma\/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling. Sci. Rep. 8, 4961 (2018).","journal-title":"Sci. Rep."},{"key":"10740_CR114","doi-asserted-by":"publisher","first-page":"e0177829","DOI":"10.1371\/journal.pone.0177829","volume":"12","author":"CSB Viegas","year":"2017","unstructured":"Viegas, C. S. B. et al. Gla-rich protein function as an anti-inflammatory agent in monocytes\/macrophages: Implications for calcification-related chronic inflammatory diseases. PLoS ONE 12, e0177829 (2017).","journal-title":"PLoS ONE"},{"key":"10740_CR115","doi-asserted-by":"crossref","unstructured":"Keefe, J. A. et al. Macrophage-mediated IL-6 signaling drives ryanodine receptor-2 calcium leak in postoperative atrial fibrillation. J. Clin. Invest. 135, e187711 (2025).","DOI":"10.1172\/JCI187711"},{"key":"10740_CR116","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.121.319737","volume":"129","author":"XS Revelo","year":"2021","unstructured":"Revelo, X. S. et al. Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis. Circ. Res. 129, 1086\u20131101 (2021).","journal-title":"Circ. Res."},{"key":"10740_CR117","first-page":"426","volume":"105","author":"JD Garcez","year":"2015","unstructured":"Garcez, J. D. et al. Patient management with metallic valve prosthesis during pregnancy and postpartum period. Arq. Bras. Cardiol. 105, 426\u2013429 (2015).","journal-title":"Arq. Bras. Cardiol."},{"key":"10740_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0049-3848(00)00379-0","volume":"101","author":"AR Rudnicka","year":"2001","unstructured":"Rudnicka, A. R., Miller, G. J., Nelson, T., Doray, D. & Comp, P. C. An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men. Thromb. Res. 101, 1\u201311 (2001).","journal-title":"Thromb. Res."},{"key":"10740_CR119","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E. & Blaxall, B. C. Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021\u20131040 (2016).","journal-title":"Circ. Res."},{"key":"10740_CR120","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc. Res. 117, 1450\u20131488 (2021).","journal-title":"Cardiovasc. Res."},{"key":"10740_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.886553","volume":"9","author":"K Schimmel","year":"2022","unstructured":"Schimmel, K., Ichimura, K., Reddy, S., Haddad, F. & Spiekerkoetter, E. Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target. Front. Cardiovasc. Med. 9, 886553 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"10740_CR122","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman, V. & Ruskoaho, H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 365, 563\u2013581 (2016).","journal-title":"Cell Tissue Res."},{"key":"10740_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1070973","volume":"14","author":"X Yin","year":"2023","unstructured":"Yin, X. et al. Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention. Front. Pharm. 14, 1070973 (2023).","journal-title":"Front. Pharm."},{"key":"10740_CR124","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.exger.2019.01.029","volume":"119","author":"FF Chen","year":"2019","unstructured":"Chen, F. F. et al. Exogenous testosterone alleviates cardiac fibrosis and apoptosis via Gas6\/Axl pathway in the senescent mice. Exp. Gerontol. 119, 128\u2013137 (2019).","journal-title":"Exp. Gerontol."},{"key":"10740_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33581","volume":"10","author":"Y Yin","year":"2024","unstructured":"Yin, Y., Ye, L., Chen, M., Liu, H. & Miao, J. Unraveling cardiomyocyte responses and intercellular communication alterations in primary carnitine deficiency cardiomyopathy via single-nucleus RNA sequencing. Heliyon 10, e33581 (2024).","journal-title":"Heliyon"},{"key":"10740_CR126","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbrc.2004.05.070","volume":"319","author":"J Stenhoff","year":"2004","unstructured":"Stenhoff, J., Dahlback, B. & Hafizi, S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochem. Biophys. Res. Commun. 319, 871\u2013878 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10740_CR127","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1164\/rccm.201707-1519OC","volume":"197","author":"MS Espindola","year":"2018","unstructured":"Espindola, M. S. et al. Targeting of TAM receptors ameliorates fibrotic mechanisms in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 197, 1443\u20131456 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10740_CR128","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10565-024-09858-5","volume":"40","author":"YJ Lee","year":"2024","unstructured":"Lee, Y. J., Kim, M., Kim, H. S. & Kang, J. L. Administration of Gas6 attenuates lung fibrosis via inhibition of the epithelial-mesenchymal transition and fibroblast activation. Cell Biol. Toxicol. 40, 20 (2024).","journal-title":"Cell Biol. Toxicol."},{"key":"10740_CR129","doi-asserted-by":"publisher","first-page":"G1043","DOI":"10.1152\/ajpgi.00311.2010","volume":"300","author":"A Fourcot","year":"2011","unstructured":"Fourcot, A. et al. Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G1043\u2013G1053 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10740_CR130","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2015.04.013","volume":"63","author":"C Barcena","year":"2015","unstructured":"Barcena, C. et al. Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J. Hepatol. 63, 670\u2013678 (2015).","journal-title":"J. Hepatol."},{"key":"10740_CR131","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2217\/bmm-2016-0210","volume":"10","author":"M Bellan","year":"2016","unstructured":"Bellan, M. et al. Gas6 as a putative noninvasive biomarker of hepatic fibrosis. Biomark. Med. 10, 1241\u20131249 (2016).","journal-title":"Biomark. Med."},{"key":"10740_CR132","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcmgh.2019.10.010","volume":"9","author":"A Tutusaus","year":"2020","unstructured":"Tutusaus, A. et al. A functional role of GAS6\/TAM in nonalcoholic steatohepatitis progression implicates AXL as therapeutic target. Cell Mol. Gastroenterol. Hepatol. 9, 349\u2013368 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10740_CR133","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41420-023-01551-6","volume":"9","author":"K Staufer","year":"2023","unstructured":"Staufer, K. et al. Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis. Cell Death Discov. 9, 282 (2023).","journal-title":"Cell Death Discov."},{"key":"10740_CR134","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.freeradbiomed.2019.01.046","volume":"134","author":"DQ Chen","year":"2019","unstructured":"Chen, D. Q. et al. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6\/AxlNFkappaB\/Nrf2 axis. Free Radic. Biol. Med. 134, 484\u2013497 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"10740_CR135","doi-asserted-by":"publisher","first-page":"e0232055","DOI":"10.1371\/journal.pone.0232055","volume":"15","author":"A Kurata","year":"2020","unstructured":"Kurata, A., Tachibana, Y., Takahashi, T. & Horiba, N. Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells. PLoS ONE 15, e0232055 (2020).","journal-title":"PLoS ONE"},{"key":"10740_CR136","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jjcc.2013.09.013","volume":"63","author":"S Zhao","year":"2014","unstructured":"Zhao, S. et al. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J. Cardiol. 63, 373\u2013378 (2014).","journal-title":"J. Cardiol."},{"key":"10740_CR137","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCRESAHA.107.149047","volume":"101","author":"T Oka","year":"2007","unstructured":"Oka, T. et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 101, 313\u2013321 (2007).","journal-title":"Circ. Res."},{"key":"10740_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26035-y","volume":"12","author":"H Gil","year":"2022","unstructured":"Gil, H. et al. Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice. Sci. Rep. 12, 21863 (2022).","journal-title":"Sci. Rep."},{"key":"10740_CR139","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s44161-022-00160-3","volume":"1","author":"DM Calcagno","year":"2022","unstructured":"Calcagno, D. M. et al. Single-cell and spatial transcriptomics of the infarcted heart define the dynamic onset of the border zone in response to mechanical destabilization. Nat. Cardiovasc. Res. 1, 1039\u20131055 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"10740_CR140","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00535-016-1206-0","volume":"51","author":"A Sugiyama","year":"2016","unstructured":"Sugiyama, A. et al. Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via alpha(v) integrin interaction. J. Gastroenterol. 51, 1161\u20131174 (2016).","journal-title":"J. Gastroenterol."},{"key":"10740_CR141","doi-asserted-by":"publisher","first-page":"12781","DOI":"10.1074\/jbc.RA117.001601","volume":"293","author":"P Kumar","year":"2018","unstructured":"Kumar, P. et al. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells. J. Biol. Chem. 293, 12781\u201312792 (2018).","journal-title":"J. Biol. Chem."},{"key":"10740_CR142","doi-asserted-by":"publisher","first-page":"e31974","DOI":"10.1371\/journal.pone.0031974","volume":"7","author":"D Guerrot","year":"2012","unstructured":"Guerrot, D. et al. Identification of periostin as a critical marker of progression\/reversal of hypertensive nephropathy. PLoS ONE 7, e31974 (2012).","journal-title":"PLoS ONE"},{"key":"10740_CR143","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2013060664","volume":"25","author":"M Mael-Ainin","year":"2014","unstructured":"Mael-Ainin, M., Abed, A., Conway, S. J., Dussaule, J. C. & Chatziantoniou, C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J. Am. Soc. Nephrol. 25, 1724\u20131736 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10740_CR144","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000485325","volume":"46","author":"JH Hwang","year":"2017","unstructured":"Hwang, J. H. et al. Experimental Inhibition of periostin attenuates kidney fibrosis. Am. J. Nephrol. 46, 501\u2013517 (2017).","journal-title":"Am. J. Nephrol."},{"key":"10740_CR145","doi-asserted-by":"publisher","first-page":"F426","DOI":"10.1152\/ajprenal.00203.2018","volume":"316","author":"JN An","year":"2019","unstructured":"An, J. N. et al. Periostin induces kidney fibrosis after acute kidney injury via the p38 MAPK pathway. Am. J. Physiol. Ren. Physiol. 316, F426\u2013F437 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10740_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44177-5","volume":"13","author":"A Cho","year":"2023","unstructured":"Cho, A. et al. Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic beta-cell dysfunction and reducing kidney EMT. Sci. Rep. 13, 17599 (2023).","journal-title":"Sci. Rep."},{"key":"10740_CR147","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41586-020-2890-8","volume":"587","author":"LM Moreira","year":"2020","unstructured":"Moreira, L. M. et al. Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia. Nature 587, 460\u2013465 (2020).","journal-title":"Nature"},{"key":"10740_CR148","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ajpath.2025.12.003","volume":"196","author":"K Bak","year":"2026","unstructured":"Bak, K. et al. Matrix Gla protein expression in pericytes and myofibroblasts contributes to renal fibrosis. Am. J. Pathol. 196, 669\u2013682 (2026).","journal-title":"Am. J. Pathol."},{"key":"10740_CR149","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","volume":"186","author":"I Noth","year":"2012","unstructured":"Noth, I. et al. Idiopathic pulmonary fibrosis clinical research N. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 186, 88\u201395 (2012).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10740_CR150","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1164\/rccm.201412-2281LE","volume":"191","author":"K Alagha","year":"2015","unstructured":"Alagha, K. et al. We should prohibit warfarin in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 191, 958\u2013960 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10740_CR151","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","volume":"59","author":"R Westenfeld","year":"2012","unstructured":"Westenfeld, R. et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am. J. Kidney Dis. 59, 186\u2013195 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"10740_CR152","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/ndt\/gft464","volume":"29","author":"R Caluwe","year":"2014","unstructured":"Caluwe, R., Vandecasteele, S., Van Vlem, B., Vermeer, C. & De Vriese, A. S. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol. Dial. Transpl. 29, 1385\u20131390 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"10740_CR153","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12882-017-0609-3","volume":"18","author":"M Aoun","year":"2017","unstructured":"Aoun, M., Makki, M., Azar, H., Matta, H. & Chelala, D. N. High dephosphorylated-uncarboxylated MGP in hemodialysis patients: risk factors and response to vitamin K(2), A pre-post intervention clinical trial. BMC Nephrol. 18, 191 (2017).","journal-title":"BMC Nephrol."},{"key":"10740_CR154","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ajpath.2016.10.006","volume":"187","author":"KA Lomashvili","year":"2017","unstructured":"Lomashvili, K. A. et al. Persistence of vascular calcification after reversal of uremia. Am. J. Pathol. 187, 332\u2013338 (2017).","journal-title":"Am. J. Pathol."},{"key":"10740_CR155","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2020.00661","volume":"11","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Role of macrophages in the progression and regression of vascular calcification. Front. Pharm. 11, 661 (2020).","journal-title":"Front. Pharm."},{"key":"10740_CR156","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.115.06265","volume":"67","author":"Y Taniyama","year":"2016","unstructured":"Taniyama, Y. et al. Selective blockade of periostin exon 17 preserves cardiac performance in acute myocardial infarction. Hypertension 67, 356\u2013361 (2016).","journal-title":"Hypertension"},{"key":"10740_CR157","first-page":"e471","volume":"150","author":"Y Kim","year":"2024","unstructured":"Kim, Y. et al. Gene therapy in cardiovascular disease: recent advances and future directions in science: a science advisory from the American Heart Association. Circulation 150, e471\u2013e480 (2024).","journal-title":"Circulation"},{"key":"10740_CR158","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41551-020-00637-1","volume":"4","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat. Biomed. Eng. 4, 1063\u20131075 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"10740_CR159","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.2147\/IJN.S533628","volume":"20","author":"Q Pan","year":"2025","unstructured":"Pan, Q., Chen, G., Zhuang, X., Li, F. & Yang, Y. Cardiac homing peptide-functionalized polymeric nanoparticles suppressing SHP1 alleviate acute myocardial infarction injury by promoting efferocytosis and inhibiting inflammation. Int. J. Nanomed. 20, 10353\u201310367 (2025).","journal-title":"Int. J. Nanomed."},{"key":"10740_CR160","doi-asserted-by":"crossref","unstructured":"Laggerbauer, B. & Engelhardt, S. MicroRNAs as therapeutic targets in cardiovascular disease. J. Clin. Invest. 132, e159179 (2022).","DOI":"10.1172\/JCI159179"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10740-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10740-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10740-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:03:01Z","timestamp":1786435381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10740-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10740"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10740-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1082"}}